CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
OcuTerra Therapeutics
OcuTerra Therapeutics logo

OcuTerra Therapeutics

OcuTerra develops innovative eye-drop, OTT166, for efficient, early treatment of diabetic eye disease.

Boston, MA, US🇺🇸
Founded
2011
Overview
Compare
Fundraising
Employees
Library

Founded with the mission to revolutionize the treatment of ophthalmic diseases, OcuTerra Therapeutics focuses on developing innovative solutions for diabetic eye disease. Their flagship product, OTT166, is a novel eye drop designed to treat diabetic retinopathy earlier and more efficiently than current methods. By offering a non-invasive, topical treatment option, OcuTerra aims to address the significant unmet need in this market, potentially transforming the standard of care for diabetic retinal disease.

OcuTerra Therapeutics has garnered attention for its promising clinical data demonstrating both safety and biological activity of OTT166. The company's efforts are supported by a team of experienced professionals and investors committed to advancing ophthalmic care. With its groundbreaking approach, OcuTerra is poised to make a substantial impact on the lives of patients with diabetic eye disease, offering a clearer vision for their future.

OcuTerra Therapeutics - Similar Companies

OcuCure Therapeutics logo

OcuCure Therapeutics

ocucure.com

PanOptica logo

PanOptica

Hyperion DeFi logo

Hyperion DeFi

eyenovia.com

Ocular Therapeutix logo

Ocular Therapeutix

ocutx.com

Vitreoretinal Technologies logo

Vitreoretinal Technologies

OcuMedic logo

OcuMedic

EyeCyte logo

EyeCyte

eyecyte.com

Ocular Science logo

Ocular Science

ocularscience.com

Surface Ophthalmics logo

Surface Ophthalmics

OcuSciences logo

OcuSciences

ocusciences.com

TherOptix logo

TherOptix

Vitranu logo

Vitranu

vitranu.com

Visus Therapeutics logo

Visus Therapeutics

visustx.com

Sydnexis logo

Sydnexis

sydnexis.com

Oculir logo

Oculir

oculir.com

OcuTerra Therapeutics - Quick Facts

Who are OcuTerra Therapeutics' competitors?

Companies similar to OcuTerra Therapeutics include OcuCure Therapeutics, PanOptica, Hyperion DeFi and Ocular Therapeutix.

When was OcuTerra Therapeutics founded?

OcuTerra Therapeutics was founded in 2011.

Where is OcuTerra Therapeutics' headquarters located?

OcuTerra Therapeutics' headquarters is located in Boston, MA, US.

When was OcuTerra Therapeutics' last funding round?

OcuTerra Therapeutics' most recent funding round was for $35M (USD) in November 2021.

How much disclosed funding has OcuTerra Therapeutics raised?

As of Nov 9, 2021, OcuTerra Therapeutics has disclosed funding of $35M (USD). Undisclosed round amounts are excluded.

How many employees does OcuTerra Therapeutics have?

OcuTerra Therapeutics has 11 employees as of Feb 5, 2024.

OcuTerra Therapeutics - Classification

Ownership
  • Venture-backed
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Eye Drops
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research